Radiopharm Theranostics’ 68Ga-RAD 301 shows promise in pancreatic cancer imaging
Radiopharm Theranostics, a clinical-stage biopharmaceutical company, has announced compelling results from a study examining the effectiveness of 68Ga-Trivehexin (68Ga-RAD 301) for imaging αvβ6-integrin expression in ... Read More